Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
United States Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: The number of new drugs approved by the FDA every year will continue to rise steadily, though this will, at least over the short term, be at a slower rate than what was seen over the 2006-2015 period. Due to advances in genomi...
Aug 2016 $ 1295
Latvia Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Latvia's pharmaceutical and healthcare markets will be shaped by the country's ongoing fiscal austerity measures. Already severely underfunded, the healthcare sector is facing additional cuts which are proving highly unpopular...
Aug 2016 $ 1295
Jordan Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Jordan presents an attractive pharmaceutical market for multinational pharmaceutical companies - although its potential will remain impeded by the ongoing political and economic instabilities within the region, which is having...
Aug 2016 $ 1295
Japan Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Competition in the Japanese biosimilar market is set to intensify over the coming years. Fundamentals attracting drugmakers into this field include its relatively nascent state, with few biosimilars launched thus far, cost con...
Aug 2016 $ 1295
Italy Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Prescription drugmakers operating in Italy will continue to face revenue challenges as spending by the country's national healthcare service, Servizio Sanitario Nazionale (SSN), continues to be restricted. The government remai...
Aug 2016 $ 1295
Denmark Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Although the Danish pharmaceutical market will post another year of weak growth for 2016, we expect the sector to slowly pick up pace over the next five years. Medicine sales will be driven by an ageing population and rising c...
Aug 2016 $ 1295
Cambodia and Laos Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Cambodia is increasingly looking to provide greater health coverage for its population and this bodes well for pharmaceutical firms over the longer term. However, consistently low levels of government health expenditure mean t...
Aug 2016 $ 1295
Bahrain Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: We expect Bahrain's pharmaceutical market will grow moderately in the coming years, with spending set to be bolstered by the eventual implantation of a national health insurance scheme. Over the longer term, the county's growi...
Aug 2016 $ 1295
Global Wilson’s Disease Market: Industry Analysis & Outlook (2016-2020)
By Koncept Analytics
Wilson’s disease is a rare disease and is named after Kinnear Wilson who was the first to describe this disorder in 1912. His description terms the disease as a “progressive lenticular degeneration,” a hereditary, fatal neurologi...
Aug 2016 $ 800
Greece Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: The government's focus on increasing the consumption of generic medicines and poor financial administration highlights Greece as a challenging market for innovative drugmakers. Despite an urgent need to reduce pharmaceutical and...
Aug 2016 $ 1295
Gabon Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Gabon's small pharmaceutical market will continue to act as a deterrent to any local investments by multinational drugmakers. Opportunities will be largely focused within the generic drug market, yet over the long term, as the n...
Aug 2016 $ 1295
Egypt Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Egypt's pharmaceutical and healthcare sector presents a high-risk investment opportunity for international drugmakers. The North African country continues to attract a significant deal of attention from multinational pharmaceuti...
Aug 2016 $ 1295
Algeria Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Algeria's large and growing healthcare and pharmaceutical market will continue to drive interest from multinational drugmakers over the forecast period. Meanwhile, Algeria's pharmaceutical exports will continue to expand as the ...
Aug 2016 $ 1295
India Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: India's pharmaceutical market will continue to see more biosimilar products being launched by domestic drugmakers. Developing such products is a business necessity for Indian firms to maintain revenue growth as commoditisation l...
Aug 2016 $ 1295
Czech Republic Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: A strong economic outlook will drive continued growth in both the pharmaceuticals and healthcare markets over the coming years. As a result of the advanced nature of the market, verging on a par with Western European markets, th...
Aug 2016 $ 1295
Cote d`Ivoire Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Côte d'Ivoire's pharmaceutical market will remain of little interest to multinational drugmakers over the coming years, with a lack of patent legislation and reimbursement regime deterring large-scale direct investment. Over the...
Aug 2016 $ 1295
Belarus Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Government initiatives to reduce the reliance on pharmaceutical imports pose challenges for multinational drugmakers. The weak ruble has seen prices of foreign medicines rise to unaffordable levels and has led to state intervent...
Aug 2016 $ 1295
Angola Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: The collapse in oil prices has impacted Angola's oil-dependant economy and government revenues. The healthcare sector is struggling to address the ever-growing needs of the people due to poor infrastructure and years of underfin...
Aug 2016 $ 1295
Osteoporosis Companies Drugs (Merck, Sanofi, Novartis, Eli Lilly and Amgen) Sales & Forecast
By Renub Research
The report titled “Osteoporosis Companies Drugs (Merck, Sanofi, Novartis, Eli Lilly and Amgen) Sales & Forecast” provides a comprehensive analysis of the current state of the market and likely future evolution over the next 5 years...
Aug 2016 $ 350
Global - Adult Vaccines Market, Company Analysis and Forecast to 2021
By iGate Research
The adult vaccines market has been forecasted to increase at a compound annual growth rate (CAGR) of around 6% over the next five years. Adults are as likely as children to die from diseases that they can be immunized. For example, vaccination can...
Aug 2016 $ 1490
Global Malignant Melanoma Market With Focus on Nevisense System: 2015-2020
By Daedal Research
Scope of the Report The report titled “Global Malignant Melanoma Market With Focus on Nevisense System: 2015-2020” provides an in-depth analysis of the global malignant melanoma market with det...
Aug 2016 $ 1200
Global Depressive Disorder Market: Industry Analysis & Outlook (2016-2020)
By Koncept Analytics
Depression is a serious mood disorder, affecting the ability to think, feel, and handle situations like sleeping, eating, or working. It is a mood disorder that causes a persistent feeling of sadness and loss of interest. It builds up a very negat...
Aug 2016 $ 800
Global Multiple Myeloma Market: Industry Analysis & Outlook (2016-2030)
By Koncept Analytics
Multiple Myeloma is a form of blood cancer. Blood cancers, or hematologic cancers, affect the production and function of blood cells. Most of these cancers start in the bone marrow where blood is produced. In myeloma, unusually large numbers of ab...
Aug 2016 $ 800
China Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: China will become a leading medical research hub within the Asia Pacific region. This will be largely led by multinational pharmaceutical firms as they seek to tap the large talent pool within the country and develop treatments ...
Jul 2016 $ 1295
Botswana Pharmaceuticals and Healthcare Report Q4 2016
By Business Monitor International
BMI View: Multinational drugmaker presence in Botswana will be limited to imports as the small market size and lack of investment incentives deter any large-scale investment plans. Although generic drugs will retain their dominance in ter...
Jul 2016 $ 1295